ProTx-III – Ion Channels and Transporters

ProTx-III (µ-TRTX-Tp1a; belongs to NaSpTx family 1) has been isolated from the venom of the Peruvian green-velvet tarantula Thrixopelma pruriens at the University of Queensland (Australia). ProTx-III has been described to be a selective inhibitor of Nav1.7 with an IC50 value around 2 nM. The synthetic version of Tp1a produced by Smartox yields similar results in terms of Nav1.7 inhibition (see Figure 1). Queensland scientists have described that ProTx-III induces no significant changes in the voltage dependence of activation or steady-state inactivation of Nav1.7. ProTx-III also inhibits Nav1.1, Nav1.2 and Nav1.6 at nanomolar concentrations and does not affects Cav channels and nicotinic acetylcholine receptors. ProTx-III demonstrates analgesic properties in vivo when injected intraplantary in mice prior treatment with OD1, an activator of Nav1.7, which induces spontaneous pain.

 

Technical specification

 KD20 peptide Sequence : H-DCLKFGWKCNPRNDKCCSGLKCGSNHNWCKLHI-NH2 (Cys2-Cys17; Cys9-Cys22; Cys16-Cys29)
 KD20 peptide MW : 3802.47 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
PTX003-0.1 mg 0.1 mg 209 € 168 $
PTX003-0.5 mg 0.5 mg 627 € 502 $
PTX003-1 mg 1 mg 990 € 792 $
PTX003-5 x 0.01 mg 5 x 0.01 mg 121 € 97 $
PTX003-

If you’d like to learn more about this toxin, visit our product page on our Smartox website—Our sister company specializing in the synthesis of complex toxins.

For Bulk Orders